Provided by Tiger Trade Technology Pte. Ltd.

Gossamer Bio Inc.

11.85
+0.27002.33%
Post-market: 11.850.00000.00%19:34 EDT
Volume:382.01K
Turnover:4.54M
Market Cap:72.43M
PE:-0.23
High:12.46
Open:11.53
Low:11.16
Close:11.58
52wk High:309.60
52wk Low:9.10
Shares:6.11M
Float Shares:3.83M
Volume Ratio:0.95
T/O Rate:9.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-51.9692
EPS(LYR):-59.6431
ROE:-783.37%
ROA:-62.39%
PB:-0.77
PE(LYR):-0.20

Loading ...

Gossamer Bio - Plans Nda Submission for Seralutinib in Pah in September 2026

THOMSON REUTERS
·
Jul 27

Gossamer Bio Announces FDA Regulatory Update and Reacquisition of Worldwide Rights Related to Seralutinib and Provides a Business Update

THOMSON REUTERS
·
Jul 27

Gossamer Bio - Chiesi to Make One-Time $5 Mln Payment to Gossamer

THOMSON REUTERS
·
Jul 27

Gossamer Bio - Reacquires Worldwide Development and Commercial Rights to Seralutinib from Chiesi

THOMSON REUTERS
·
Jul 27

Gossamer Bio Inc: Co and Chiesi Agreed to Terminate Their Collaboration and License Agreement

THOMSON REUTERS
·
Jul 27

Gossamer Bio Shareholders Approve Charter Amendment Increasing Authorized Common Shares to 4 Billion

Reuters
·
Jul 15

Gossamer Bio announces determination of conversion rate for senior secured notes

TIPRANKS
·
Jul 01

Gossamer Bio, Inc. Announces Determination of Conversion Rate for 7.50% Convertible Senior Secured First Lien Notes Due 2030 and Exercise Price for Purchase Warrants

THOMSON REUTERS
·
Jul 01

Gossamer Bio is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jun 26

Gossamer Bio price target lowered to $2 from $5 at H.C. Wainwright

TIPRANKS
·
Jun 26

Gossamer Bio Insiders Are Down US$45k But Regain Some Losses

Simply Wall St.
·
Jun 18

Gossamer Bio announces final tender results

TIPRANKS
·
Jun 17

Gossamer Bio says $18.95 million of 5% convertible notes due 2027 remain after exchange offer

Reuters
·
Jun 17

Gossamer Bio, Inc. Announces Final Tender Results for Exchange Offer and Consent Solicitation With Respect to Existing Convertible Notes

THOMSON REUTERS
·
Jun 17

Gossamer Bio - $181.1 Mln of Existing Convertible Notes Tendered as of June 2, 2026

THOMSON REUTERS
·
Jun 17

Gossamer Bio - Eliminates Most Restrictive Covenants and Events of Default on Existing Notes

THOMSON REUTERS
·
Jun 17

Harbour BioMed appoints Luisa Salter-Cid as scientific advisor

Reuters
·
Jun 11

Gossamer Bio accepts early tenders of USD 181.05 million 5% convertible notes in exchange offer

Reuters
·
Jun 05

Gossamer Bio shareholders re-elect Hasnain, Cox to board as Class II directors

Reuters
·
Jun 05

Gossamer Bio announces early tender results, early settlement of solicitation

TIPRANKS
·
Jun 03